IRIC – Institut de recherche en immunologie et en cancérologie de l’Université de Montréal

Navigation principale

  • À propos
    • Notre Institut
    • Notre équipe de gouvernance
    • Actualités
    • Événements
    • Subventions
  • Recherche
    • L’importance de la recherche
    • Chercheurs
    • Domaines de recherche
    • Plateformes et infrastructures
    • Publications
    • Conférences
  • Formation
    • Étudier à l’IRIC
    • Nos programmes
    • Soumettre votre candidature
  • Valorisation
  • Carrières
    • Postes disponibles
    • Candidature spontanée
  • Soutenez la recherche
    • Je fais un don
    • Je participe
    • Je contribue autrement
    • Impact des dons
    • Nos donateurs
  • Répertoire de l’IRIC
  • Outils
  • Salle de presse
  • Contact
  • L’IRIC a 20 ans!
  • Soutenez la recherche
    • Je fais un don
    • Je participe
    • Je contribue autrement
    • Impact des dons
    • Nos donateurs
  • Chercher sur le site
  • EN

Fil d’Ariane

  • Accueil
  • Chercher sur le site
  • Accueil

Chercher sur le site

173 résultats


Publications — IRIC 1er janvier 2023

Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD.

Claveau JS, LeBlanc R, Ahmad I, Delisle JS, Cohen S, Kiss T, Bambace NM, Bernard L, Lachance S, Roy DC, Sauvageau G, Veilleux O, Roy J
Transplant Cell Ther 2023-01-01 ;29( 1 ):44.e1-44.e9.


Publications — IRIC 1er janvier 2023

Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.

Lachance S, Bourguignon A, Boisjoly JA, Bouchard P, Ahmad I, Bambace N, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Veilleux O, Zehr J, Chagnon M, Roy J
Transplant Cell Ther 2023-01-01 ;29( 1 ):34.e1-34.e7.


Publications — IRIC 13 septembre 2022

Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia.

Lisi V, Blanchard E, Vladovsky M, Audemard E, Ferghaly A, Lemieux S, Hébert J, Sauvageau G, Lavallée VP
Blood Adv 2022-09-13 ;6( 17 ):5160-5164.


Publications — IRIC 23 août 2022

HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.

Moison C, Spinella JF, Chagraoui J, Lavallée VP, Lehnertz B, Thiollier C, Boivin I, Mayotte N, MacRae T, Marinier A, Hébert J, Sauvageau G
Blood Adv 2022-08-23 ;6( 16 ):4793-4806.


Publications — IRIC 22 août 2022

Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Kadri Y, Phan M, Bambace N, Bernard L, Cohen S, Delisle JS, Kiss T, Lachance S, Roy DC, Sauvageau G, Veilleux O, Roy J, Ahmad I
Curr Oncol 2022-08-22 ;29( 8 ):5955-5962.


Publications — IRIC 1er juillet 2022

Hyaluronic acid-GPRC5C signalling promotes dormancy in haematopoietic stem cells.

Zhang YW, Mess J, Aizarani N, Mishra P, Johnson C, Romero-Mulero MC, Rettkowski J, Schönberger K, Obier N, Jäcklein K, Woessner NM, Lalioti ME, Velasco-Hernandez T, Sikora K, Wäsch R, Lehnertz B, Sauvageau G, Manke T, Menendez P, Walter SG, Minguet S, Laurenti E, Günther S, Grün D, Cabezas-Wallscheid N
Nat Cell Biol 2022-07-01 ;24( 7 ):1038-1048.


Publications — IRIC 1er juillet 2022

UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities.

Dumont-Lagacé M, Feghaly A, Meunier MC, Finney M, Van't Hof W, Masson Frenet E, Sauvageau G, Cohen S
Transplant Cell Ther 2022-07-01 ;28( 7 ):410.e1-410.e5.


Publications — IRIC 28 juin 2022

CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells.

Ansari U, Tomellini E, Chagraoui J, Lehnertz B, Mayotte N, Bordeleau ME, Roux PP, Sauvageau G
Blood Adv 2022-06-28 ;6( 12 ):3626-3631.


Publications — IRIC 19 mai 2022

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.

Baran N, Lodi A, Dhungana Y, Herbrich S, Collins M, Sweeney S, Pandey R, Skwarska A, Patel S, Tremblay M, Kuruvilla VM, Cavazos A, Kaplan M, Warmoes MO, Veiga DT, Furudate K, Rojas-Sutterin S, Haman A, Gareau Y, Marinier A, Ma H, Harutyunyan K, Daher M, Garcia LM, Al-Atrash G, Piya S, Ruvolo V, Yang W, Shanmugavelandy SS, Feng N, Gay J, Du D, Yang JJ, Hoff FW, Kaminski M, Tomczak K, Eric Davis R, Herranz D, Ferrando A, Jabbour EJ, Emilia Di Francesco M, Teachey DT, Horton TM, Kornblau S, Rezvani K, Sauvageau G, Gagea M, Andreeff M, Takahashi K, Marszalek JR, Lorenzi PL, Yu J, Tiziani S, Hoang T, Konopleva M
Nat Commun 2022-05-19 ;13( 1 ):2801.


Publications — IRIC 7 mars 2022

CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia.

He L, Arnold C, Thoma J, Rohde C, Kholmatov M, Garg S, Hsiao CC, Viol L, Zhang K, Sun R, Schmidt C, Janssen M, MacRae T, Huber K, Thiede C, Hébert J, Sauvageau G, Spratte J, Fluhr H, Aust G, Müller-Tidow C, Niehrs C, Pereira G, Hamann J, Tanaka M, Zaugg JB, Pabst C
EMBO Mol Med 2022-03-07 ;e14990.


Publications — IRIC 1er mars 2022

Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.

Veilleux O, Claveau JS, Alaoui H, Roy J, Ahmad I, Delisle JS, Kiss T, Bambace NM, Bernard L, Cohen S, Sauvageau G, Fleury I, Mollica L, Roy DC, Serroukh Y, Lachance S
Transplant Cell Ther 2022-03-01 ;28( 3 ):145-151.


Publications — IRIC 1er février 2022

Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study.

LeBlanc R, Ahmad I, Terra R, Boudreault JS, Ogez D, Lamore K, Delisle JS, Bambace N, Bernard L, Cohen S, Kiss T, Lachance S, Landais S, Lemieux-Blanchard E, Sauvageau G, Sebag M, Roy DC, Roy J
Bone Marrow Transplant 2022-02-01 ;57( 2 ):252-260.


Publications — IRIC 25 janvier 2022

Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.

Krosl J, Bordeleau ME, Moison C, MacRae T, Boivin I, Mayotte N, Gracias D, Baccelli I, Lavallée VP, Bisaillon R, Lehnertz B, Mendoza-Sanchez R, Ruel R, Bertomeu T, Coulombe-Huntington J, Boucher G, Noronha N, Pabst C, Tyers M, Gendron P, Lemieux S, Barabé F, Marinier A, Hébert J, Sauvageau G
Blood Adv 2022-01-25 ;6( 2 ):509-514.


Publications — IRIC 23 décembre 2021

HLF expression defines the human hematopoietic stem cell state.

Lehnertz B, Chagraoui J, MacRae T, Tomellini E, Corneau S, Mayotte N, Boivin I, Durand A, Gracias D, Sauvageau G
Blood 2021-12-23 ;138( 25 ):2642-2654.


Publications — IRIC 11 novembre 2021

Legal and Ethical Considerations for the Design and Use of Web Portals for Researchers, Clinicians, and Patients: Scoping Literature Review.

Lang M, Lemieux S, Hébert J, Sauvageau G, Zawati MH
J Med Internet Res 2021-11-11 ;23( 11 ):e26450.


Publications — IRIC 12 août 2021

A genetic screen in Drosophila uncovers the multifaceted properties of the NUP98-HOXA9 oncogene.

Gavory G, Baril C, Laberge G, Bidla G, Koonpaew S, Sonea T, Sauvageau G, Therrien M
PLoS Genet 2021-08-12 ;17( 8 ):e1009730.


Publications — IRIC 1er juillet 2021

Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML.

Herbrich S, Baran N, Cai T, Weng C, Aitken MJL, Post SM, Henderson J, Shi C, Richard-Carpentier G, Sauvageau G, Baggerly K, Al-Atrash G, Davis RE, Daver N, Zha D, Konopleva M
J Immunother Cancer 2021-07-01 ;9( 7 ):.


Publications — IRIC 30 avril 2021

Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia.

Supper E, Rudat S, Iyer V, Droop A, Wong K, Spinella JF, Thomas P, Sauvageau G, Adams DJ, Wong CC
Nat Commun 2021-04-30 ;12( 1 ):2482.


Publications — IRIC 13 avril 2021

Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes.

Ehx G, Larouche JD, Durette C, Laverdure JP, Hesnard L, Vincent K, Hardy MP, Thériault C, Rulleau C, Lanoix J, Bonneil E, Feghaly A, Apavaloaei A, Noronha N, Laumont CM, Delisle JS, Vago L, Hébert J, Sauvageau G, Lemieux S, Thibault P, Perreault C
Immunity 2021-04-13 ;54( 4 ):737-752.e10.


Publications — IRIC 16 mars 2021

Zinc finger protein E4F1 cooperates with PARP-1 and BRG1 to promote DNA double-strand break repair.

Moison C, Chagraoui J, Caron MC, Gagné JP, Coulombe Y, Poirier GG, Masson JY, Sauvageau G
Proc Natl Acad Sci U S A 2021-03-16 ;118( 11 ):.


Publications — IRIC 7 janvier 2021

UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.

Chagraoui J, Girard S, Spinella JF, Simon L, Bonneil E, Mayotte N, MacRae T, Coulombe-Huntington J, Bertomeu T, Moison C, Tomellini E, Thibault P, Tyers M, Marinier A, Sauvageau G
Cell Stem Cell 2021-01-07 ;28( 1 ):48-62.e6.


Publications — IRIC 1er janvier 2021

UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections.

Dumont-Lagacé M, Li Q, Tanguay M, Chagraoui J, Kientega T, Cardin GB, Brasey A, Trofimov A, Carli C, Ahmad I, Bambace NM, Bernard L, Kiss TL, Roy J, Roy DC, Lemieux S, Perreault C, Rodier F, Dufresne SF, Busque L, Lachance S, Sauvageau G, Cohen S, Delisle JS
Transplant Cell Ther 2021-01-01 ;27( 1 ):76.e1-76.e9.


Publications — IRIC 1er décembre 2020

Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors.

Claveau JS, Cohen S, Ahmad I, Delisle JS, Kiss T, Lachance S, Sauvageau G, Busque L, Brito RM, Bambace N, Bernard L, Roy DC, Roy J
Eur J Haematol 2020-12-01 ;105( 6 ):808-811.


Publications — IRIC 27 septembre 2020

Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only.

LeBlanc R, Claveau JS, Ahmad I, Delisle JS, Bambace N, Bernard L, Cohen S, Kiss T, Lachance S, Landais S, Roy DC, Sauvageau G, Roy J
Clin Transplant 2020-09-27 ;e14099.


Publications — IRIC 13 février 2020

High frequency of germline RUNX1 mutations in RUNX1 mutated AML patients.

Simon L, Spinella JF, Yao CY, Lavallée VP, Boivin I, Boucher G, Audemard E, Bordeleau ME, Lemieux S, Hebert J, Sauvageau G
Blood 2020-02-13 ;.


Publications — IRIC 31 janvier 2020

Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.

Cohen S, Roy J, Lachance S, Delisle JS, Marinier A, Busque L, Roy DC, Barabé F, Ahmad I, Bambace N, Bernard L, Kiss T, Bouchard P, Caudrelier P, Landais S, Larochelle F, Chagraoui J, Lehnertz B, Corneau S, Tomellini E, van Kampen JJA, Cornelissen JJ, Dumont-Lagacé M, Tanguay M, Li Q, Lemieux S, Zandstra PW, Sauvageau G
Lancet Haematol 2020-01-31 ;7( 2 ):e134-e145.


Publications — IRIC 21 décembre 2019

Pathways, Processes, and Candidate Drugs Associated with a Hoxa Cluster-Dependency Model of Leukemia.

Kettyle LM, Lebert-Ghali CE, Grishagin IV, Dickson GJ, O'Reilly PG, Simpson DA, Bijl JJ, Mills KI, Sauvageau G, Thompson A
Cancers (Basel) 2019-12-21 ;11( 12 ):.


Publications — IRIC 19 décembre 2019

Genetic characterization of ABT-199 sensitivity in human AML.

Bisaillon R, Moison C, Thiollier C, Krosl J, Bordeleau ME, Lehnertz B, Lavallée VP, MacRae T, Mayotte N, Labelle C, Boucher G, Spinella JF, Boivin I, D'Angelo G, Lavallée S, Marinier A, Lemieux S, Hébert J, Sauvageau G
Leukemia 2019-12-19 ;34( 1 ):63-74.


Publications — IRIC 2 décembre 2019

Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting.

Tremblay G, Rousseau B, Marquis M, Beaubois C, Sauvageau G, Hébert J
Appl Health Econ Health Policy 2019-12-02 ;17( 6 ):827-839.


Publications — IRIC 29 novembre 2019

The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.

Angenendt L, Bormann E, Pabst C, Alla V, Görlich D, Braun L, Dohlich K, Schwöppe C, Bohlander SK, Arteaga MF, Wethmar K, Hartmann W, Angenendt A, Kessler T, Mesters RM, Stelljes M, Rothenberg-Thurley M, Spiekermann K, Hébert J, Sauvageau G, Valk PJM, Löwenberg B, Serve H, Müller-Tidow C, Lenz G, Wörmann BJ, Sauerland MC, Hiddemann W, Berdel WE, Krug U, Metzeler KH, Mikesch JH, Herold T, Schliemann C
Leukemia 2019-11-29 ;33( 12 ):2830-2841.


Publications — IRIC 17 novembre 2019

UM171 induces a homeostatic inflammatory-detoxification response supporting human HSC self-renewal.

Chagraoui J, Lehnertz B, Girard S, Spinella JF, Fares I, Tomellini E, Mayotte N, Corneau S, MacRae T, Simon L, Sauvageau G
PLoS ONE 2019-11-17 ;14( 11 ):e0224900.


Publications — IRIC 12 septembre 2019

Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Lymphoma Patients.

Lemieux C, Ahmad I, Bambace NM, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Roy J, Lachance S
Biol. Blood Marrow Transplant. 2019-09-12 ;.


Publications — IRIC 1er septembre 2019

Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis.

Roy DC, Lachance S, Cohen S, Delisle JS, Kiss T, Sauvageau G, Busque L, Ahmad I, Bernard L, Bambace N, Boumédine RS, Guertin MC, Rezvani K, Mielke S, Perreault C, Roy J
Br. J. Haematol. 2019-09-01 ;186( 5 ):754-766.


Publications — IRIC 22 août 2019

A Fanci knockout mouse model reveals common and distinct functions for FANCI and FANCD2.

Dubois EL, Guitton-Sert L, Béliveau M, Parmar K, Chagraoui J, Vignard J, Pauty J, Caron MC, Coulombe Y, Buisson R, Jacquet K, Gamblin C, Gao Y, Laprise P, Lebel M, Sauvageau G, D d'Andrea A, Masson JY
Nucleic Acids Res. 2019-08-22 ;47( 14 ):7532-7547.


Publications — IRIC 1er août 2019

Targeted variant detection using unaligned RNA-Seq reads.

Audemard EO, Gendron P, Feghaly A, Lavallée VP, Hébert J, Sauvageau G, Lemieux S
Life Sci Alliance 2019-08-01 ;2( 4 ):.


Publications — IRIC 23 juillet 2019

Integrin-α3 Is a Functional Marker of Ex Vivo Expanded Human Long-Term Hematopoietic Stem Cells.

Tomellini E, Fares I, Lehnertz B, Chagraoui J, Mayotte N, MacRae T, Bordeleau MÈ, Corneau S, Bisaillon R, Sauvageau G
Cell Rep 2019-07-23 ;28( 4 ):1063-1073.e5.


Publications — IRIC 18 juillet 2019

Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML.

Garg S, Reyes-Palomares A, He L, Bergeron A, Lavallée VP, Lemieux S, Gendron P, Rohde C, Xia J, Jagdhane P, Müller-Tidow C, Lipka DB, Imren S, Humphries RK, Waskow C, Vick B, Jeremias I, Richard-Carpentier G, Hébert J, Sauvageau G, Zaugg JB, Barabé F, Pabst C
Blood 2019-07-18 ;134( 3 ):263-276.


Publications — IRIC 8 juillet 2019

Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.

Baccelli I, Gareau Y, Lehnertz B, Gingras S, Spinella JF, Corneau S, Mayotte N, Girard S, Frechette M, Blouin-Chagnon V, Leveillé K, Boivin I, MacRae T, Krosl J, Thiollier C, Lavallée VP, Kanshin E, Bertomeu T, Coulombe-Huntington J, St-Denis C, Bordeleau ME, Boucher G, Roux PP, Lemieux S, Tyers M, Thibault P, Hébert J, Marinier A, Sauvageau G
Cancer Cell 2019-07-08 ;36( 1 ):84-99.e8.


Publications — IRIC 1er avril 2019

Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.

Lemieux C, Ahmad I, Bambace NM, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Roy J, Lachance S
Leuk. Res. 2019-04-01 ;79:75-80.


Publications — IRIC 26 février 2019

Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition.

Moison C, Lavallée VP, Thiollier C, Lehnertz B, Boivin I, Mayotte N, Gareau Y, Fréchette M, Blouin-Chagnon V, Corneau S, Lavallée S, Lemieux S, Marinier A, Hébert J, Sauvageau G
Blood Adv 2019-02-26 ;3( 4 ):552-563.


Publications — IRIC 19 juillet 2018

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.

Marquis M, Beaubois C, Lavallée VP, Abrahamowicz M, Danieli C, Lemieux S, Ahmad I, Wei A, Ting SB, Fleming S, Schwarer A, Grimwade D, Grey W, Hills RK, Vyas P, Russell N, Sauvageau G, Hébert J
Blood Cancer J 2018-07-19 ;8( 8 ):68.


Publications — IRIC 5 juillet 2018

UM171 Enhances Lentiviral Gene Transfer and Recovery of Primitive Human Hematopoietic Cells.

Ngom M, Imren S, Maetzig T, Adair JE, Knapp D, Chagraoui J, Fares I, Bordeleau ME, Sauvageau G, Leboulch P, Eaves C, Humphries RK
Mol Ther Methods Clin Dev 2018-07-05 ;10:156-164.


Publications — IRIC 1er juin 2018

Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin.

Lavallée VP, Chagraoui J, MacRae T, Marquis M, Bonnefoy A, Krosl J, Lemieux S, Marinier A, Pabst C, Rivard GÉ, Hébert J, Sauvageau G
Leukemia 2018-06-01 ;32( 6 ):1349-1357.


Publications — IRIC 1er avril 2018

MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.

Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, Bhola P, O'Donnell C, Spitzer B, Stutzke C, Lavallée VP, Hébert J, Krivtsov AV, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G, Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A
Cancer Discov 2018-04-01 ;8( 4 ):478-497.


Publications — IRIC 16 novembre 2017

H3K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations.

Lehnertz B, Zhang YW, Boivin I, Mayotte N, Tomellini E, Chagraoui J, Lavallée VP, Hébert J, Sauvageau G
Blood 2017-11-16 ;130( 20 ):2204-2214.


Publications — IRIC 15 novembre 2017

Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity.

Simon L, Lavallée VP, Bordeleau ME, Krosl J, Baccelli I, Boucher G, Lehnertz B, Chagraoui J, MacRae T, Ruel R, Chantigny Y, Lemieux S, Marinier A, Hébert J, Sauvageau G
Clin. Cancer Res. 2017-11-15 ;23( 22 ):6969-6981.


Publications — IRIC 1er novembre 2017

UBAP2L is amplified in a large subset of human lung adenocarcinoma and is critical for epithelial lung cell identity and tumor metastasis.

Aucagne R, Girard S, Mayotte N, Lehnertz B, Lopes-Paciencia S, Gendron P, Boucher G, Chagraoui J, Sauvageau G
FASEB J. 2017-11-01 ;31( 11 ):5012-5018.


Publications — IRIC 27 juillet 2017

MiSTIC, an integrated platform for the analysis of heterogeneity in large tumour transcriptome datasets.

Lemieux S, Sargeant T, Laperrière D, Ismail H, Boucher G, Rozendaal M, Lavallée VP, Ashton-Beaucage D, Wilhelm B, Hébert J, Hilton DJ, Mader S, Sauvageau G
Nucleic Acids Res. 2017-07-27 ;45( 13 ):e122.


Publications — IRIC 1er juillet 2017

AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.

Zhou F, Liu Y, Rohde C, Pauli C, Gerloff D, Köhn M, Misiak D, Bäumer N, Cui C, Göllner S, Oellerich T, Serve H, Garcia-Cuellar MP, Slany R, Maciejewski JP, Przychodzen B, Seliger B, Klein HU, Bartenhagen C, Berdel WE, Dugas M, Taketo MM, Farouq D, Schwartz S, Regev A, Hébert J, Sauvageau G, Pabst C, Hüttelmaier S, Müller-Tidow C
Nat. Cell Biol. 2017-07-01 ;19( 7 ):844-855.


Publications — IRIC 22 juin 2017

EPCR expression marks UM171-expanded CD34(+) cord blood stem cells.

Fares I, Chagraoui J, Lehnertz B, MacRae T, Mayotte N, Tomellini E, Aubert L, Roux PP, Sauvageau G
Blood 2017-06-22 ;129( 25 ):3344-3351.

Voir plus de résultats
Filtres de recherche

Filtres de recherche

Ouvrir l’accordéon

Filtres
de recherche

Fermer l’accordéon
Filtres actifs
Publications
Guy Sauvageau
Types de contenus
  • Publications (173)
Chercheurs
  • Anne Marinier (16)
  • Benjamin Kwok (1)
  • Brian Wilhelm (12)
  • Claude Perreault (10)
  • David Knapp (3)
  • Guy Sauvageau (173)
  • Julie Lessard (12)
  • Louis Gaboury (2)
  • Marc Therrien (2)
  • Michael Tyers (3)
  • Michel Bouvier (1)
  • Philippe P. Roux (4)
  • Pierre Thibault (7)
  • Sylvain Meloche (8)
  • Sylvie Mader (1)
  • Sébastien Lemieux (33)
  • Trang Hoang (5)
Domaines de recherche
  • Analyse computationnelle & modélisation (50)
  • Biologie chimique & structurale (24)
  • Division cellulaire & migration (14)
  • Génomique & épigénétique (173)
  • Immunologie & hématopoïèse (173)
  • Signalisation cellulaire et dynamique des protéines (20)
  • Thérapies ciblées & outils diagnostiques (173)
Années
  • 2023 (2)
  • 2022 (11)
  • 2021 (9)
  • 2020 (4)
  • 2019 (14)
  • 2018 (4)
  • 2017 (11)
  • 2016 (9)
  • 2015 (6)
  • 2014 (11)
  • 2013 (6)
  • 2012 (6)
  • 2011 (6)
  • 2010 (8)
  • 2009 (5)
  • 2008 (6)
  • 2007 (5)
  • 2006 (6)
  • 2005 (5)
  • 2004 (5)
  • 2003 (4)
  • 2002 (4)
  • 2001 (4)
  • 2000 (1)
  • 1999 (3)
  • 1998 (3)
  • 1997 (4)
  • 1996 (4)
  • 1995 (2)
  • 1994 (1)
  • 1991 (1)
  • 1990 (2)
  • 1988 (1)
IRIC – Institut de recherche en immunologie et en cancérologie de l’Université de Montréal

Navigation principale

  • À propos
  • Recherche
  • Formation
  • Valorisation
  • Carrières
  • Soutenez la recherche
  • Répertoire de l’IRIC
  • Salle de presse
  • Outils
  • Contact

IRIC | Université de Montréal
2950, Chemin de Polytechnique
Pavillon Marcelle-Coutu
Montréal, Québec  H3T 1J4
Canada

Comment se rendre à l’IRIC?

Téléphone
+1 (514) 343-7770
Télécopieur
+1 (514) 343-7780

Réseaux sociaux

Inscription à l’infolettre
Inscription à l’infolettre

Navigation secondaire

  • Termes et conditions
  • Politique de confidentialité

© 2003-2023 IRIC. Tous droits réservés.

Site web par Principal